Chronic Hepatitis-C-Infection Genotype 1, 4 and 6: High Cure Rates with Grazoprevir/Elbasvir for i. v. -Drug Users under Opioid-Agonist-Treatment

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:65 / 65
页数:1
相关论文
共 16 条
  • [2] US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection
    Sarita D. Boyd
    LaRee Tracy
    Takashi E. Komatsu
    Patrick R. Harrington
    Prabha Viswanathan
    Jeff Murray
    Adam Sherwat
    Clinical Drug Investigation, 2017, 37 : 317 - 326
  • [3] US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection
    Boyd, Sarita D.
    Tracy, LaRee
    Komatsu, Takashi E.
    Harrington, Patrick R.
    Viswanathan, Prabha
    Murray, Jeff
    Sherwat, Adam
    CLINICAL DRUG INVESTIGATION, 2017, 37 (04) : 317 - 326
  • [4] Elbasvir/Grazoprevir in Asia-Pacific/Russian Participants With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
    George, Jacob
    Burnevich, Eduard
    Sheen, I-Shyan
    Heo, Jeong
    Nguyen Van Kinh
    Tanwandee, Tawesak
    Cheng, Pin-Nan
    Kim, Do Young
    Tak, Won Young
    Kizhlo, Svetlana
    Zhdanov, Konstantin
    Isakov, Vasily
    Liang, Liwen
    Lindore, Pauline
    Ginanni, Joy
    Nguyen, Bach-Yen
    Wahl, Janice
    Barr, Eliav
    Robertson, Michael
    Ingravallo, Paul
    Talwani, Rohit
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (05) : 595 - 606
  • [5] Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection who receive opioid agonist therapy: Treatment utilization and the impact of concomitant psychiatric medications
    Kramer, Jennifer
    Puenpatom, Amy
    Cao, Yumei
    El-Serag, Hashem
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E112 - E112
  • [7] Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection A Randomized Trial
    Zeuzem, Stefan
    Ghalib, Reem
    Reddy, K. Rajender
    Pockros, Paul J.
    Ben Ari, Ziv
    Zhao, Yue
    Brown, Deborah D.
    Wan, Shuyan
    DiNubile, Mark J.
    Bach-Yen Nguyen
    Robertson, Michael N.
    Wahl, Janice
    Barr, Eliav
    Butterton, Joan R.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (01) : 1 - 13
  • [8] High Efficacy in Patients With Chronic Hepatitis C Virus (HCV) Genotype (GT) 1b Infection Treatment With Elbasvir/Grazoprevir for 12 Weeks: An Integrated Analysis
    Zeuzem, Stefan
    Serfaty, Lawrence
    Vierling, John M.
    Cheng, Wendy
    George, Jacob
    Sperl, Jan
    Strasser, Simone I.
    Kumada, Hiromitsu
    Hwang, Peggy
    Robertson, Michael
    Wahl, Janice
    Barr, Eliav
    Talwani, Rohit
    Platt, Heather L.
    HEPATOLOGY, 2016, 64 : 433A - 433A
  • [9] C-SWIFT: GRAZOPREVIR/ELBASVIR plus SOFOSBUVIR IN CIRRHOTIC AND NONCIRRHOTIC, TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION, FOR DURATIONS OF 4, 6 OR 8 WEEKS AND GENOTYPE 3 INFECTION FOR DURATIONS OF 8 OR 12 WEEKS
    Poordad, F.
    Lawitz, E.
    Gutierrez, J. A.
    Evans, B.
    Howe, A.
    Feng, H. -P.
    Li, J. J.
    Hwang, P.
    Robertson, M.
    Wahl, J.
    Barr, E.
    Haber, B.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S192 - S193
  • [10] Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
    Roth, David
    Nelson, David R.
    Bruchfeld, Annette
    Liapakis, AnnMarie
    Silva, Marcelo
    Monsour, Howard, Jr.
    Martin, Paul
    Pol, Stanislas
    Londono, Maria-Carlota
    Hassanein, Tarek
    Zamor, Philippe J.
    Zuckerman, Eli
    Wan, Shuyan
    Jackson, Beth
    Nguyen, Bach-Yen
    Robertson, Michael
    Barr, Eliav
    Wahl, Janice
    Greaves, Wayne
    LANCET, 2015, 386 (10003): : 1537 - 1545